These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6775032)

  • 1. Human seminal plasma inhibition of complement.
    Petersen BH; Lammel CJ; Stites DP; Brooks GF
    J Lab Clin Med; 1980 Oct; 96(4):582-91. PubMed ID: 6775032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human seminal plasma inhibition of antibody complement-mediated killing and opsonization of Neisseria gonorrhoeae and other gram-negative organisms.
    Brooks GF; Lammel CJ; Petersen BH; Stites DP
    J Clin Invest; 1981 May; 67(5):1523-31. PubMed ID: 6785314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete absence of the third component of complement in man.
    Ballow M; Shira JE; Harden L; Yang SY; Day NK
    J Clin Invest; 1975 Sep; 56(3):703-10. PubMed ID: 1159084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.
    Schweinle JE; Hitchcock PJ; Tenner AJ; Hammer CH; Frank MM; Joiner KA
    J Clin Invest; 1989 Feb; 83(2):397-403. PubMed ID: 2492308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.
    Petersen BH; Graham JA; Brooks GF
    J Clin Invest; 1976 Feb; 57(2):283-90. PubMed ID: 815273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis.
    Akalin HE; Laleli Y; Telatar H
    Q J Med; 1985 Aug; 56(220):431-7. PubMed ID: 3901076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanism for decreased resistance to infection by gram-negative organisms during acute alcoholic intoxication.
    Marr JJ; Spilberg I
    J Lab Clin Med; 1975 Aug; 86(2):253-8. PubMed ID: 807663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
    Fierer J; Finley F
    J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
    Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
    J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificities of the protease of mouse serum Ra-reactive factor.
    Ogata RT; Low PJ; Kawakami M
    J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.
    Hill AW; Shears AL; Hibbitt KG
    Immunology; 1978 Jan; 34(1):131-6. PubMed ID: 75177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticomplementary activity of a polyanion: pentosan-poly-sulfoester, II.--Mode of action and "in vitro " inhibition of human complement hemolytic activity (author's transl)].
    Berthoux FX; Freyria AM; Traeger J
    Pathol Biol (Paris); 1977 Feb; 25(2):105-8. PubMed ID: 322041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.
    Baker PJ; Osofsky SG
    Clin Exp Immunol; 1981 Mar; 43(3):549-56. PubMed ID: 6912799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae.
    Ingwer I; Petersen BH; Brooks G
    J Lab Clin Med; 1978 Aug; 92(2):211-20. PubMed ID: 98602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies on doses of complement for detection of sperm immobilizing antibody in serum, cervical mucus and seminal plasma (author's transl)].
    Kamata T; Takada Y; Ikuma K; Kubota K; Koyama K; Isojima S
    Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):786-92. PubMed ID: 7246065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of the plaque assay to determine the sensitivity of Neisseria gonorrhoeae to the bactericidal activity of normal human serum.
    Odum L
    Acta Pathol Microbiol Immunol Scand B; 1982 Apr; 90(2):141-4. PubMed ID: 6805252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.